Glenn Frank Short is Chief Scientific Officer of ATAI Life Sciences N.V.. Currently has a direct ownership of 42,333 shares of ATAI, which is worth approximately $62,229. The most recent transaction as insider was on Mar 21, 2025, when has been sold 13,161 shares (Common Shares) at a price of $1.35 per share, resulting in proceeds of $17,767. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42.3K
n/a 3M change
n/a 12M change
Total Value Held $62,229

Glenn Frank Short Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2025
SELL
Open market or private sale
$17,767 $1.35 p/Share
13,161 Reduced 23.72%
42,333 Common Shares
Mar 14 2025
BUY
Exercise of conversion of derivative security
-
32,500 Added 36.93%
55,494 Common Shares
GFS

Glenn Frank Short

Chief Scientific Officer
Berlin, 2M

Track Institutional and Insider Activities on ATAI

Follow ATAI Life Sciences N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATAI shares.

Notify only if

Insider Trading

Get notified when an Atai Life Sciences N.V. insider buys or sells ATAI shares.

Notify only if

News

Receive news related to ATAI Life Sciences N.V.

Track Activities on ATAI